Heart Failure in Adults With Congenital Heart Disease

[1]  K. Dimopoulos,et al.  Past and current cause-specific mortality in Eisenmenger syndrome , 2017, European heart journal.

[2]  A. Opotowsky,et al.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease , 2017, Current Cardiology Reports.

[3]  J. Roos‐Hesselink,et al.  Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease , 2017, Circulation.

[4]  S. Waikar,et al.  Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation , 2016, Heart.

[5]  A. Tzifa,et al.  Magnetic resonance imaging catheter stress haemodynamics post-Fontan in hypoplastic left heart syndrome. , 2016, European heart journal cardiovascular Imaging.

[6]  A. Dubart,et al.  Late diagnosis of isolated congenitally corrected transposition of the great arteries in a 92-year old woman. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  A. Kovacs,et al.  Prevalence and Correlates of Post-traumatic Stress Disorder in Adults With Congenital Heart Disease. , 2016, The American journal of cardiology.

[8]  K. Dimopoulos,et al.  Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[9]  K. Dimopoulos,et al.  Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association , 2016, Circulation.

[10]  B. Deal,et al.  Fontan conversion: guidelines from Down Under. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  J. Galati,et al.  Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  S. Ebrahim,et al.  Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[13]  E. Rimm,et al.  Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation , 2016, Journal of the American Heart Association.

[14]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[15]  Natalia C. Berry,et al.  Protocol for Exercise Hemodynamic Assessment: Performing an Invasive Cardiopulmonary Exercise Test in Clinical Practice , 2015, Pulmonary circulation.

[16]  C. Silversides,et al.  Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation. , 2015, International journal of cardiology.

[17]  W. Budts,et al.  Can a volume challenge pinpoint the limiting factor in a Fontan circulation? , 2015, Acta cardiologica.

[18]  K. Dimopoulos,et al.  Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre , 2015, Circulation.

[19]  J. Barberà,et al.  Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. , 2015, The New England journal of medicine.

[20]  C. Ukomadu,et al.  Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  C. Broberg,et al.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease. , 2015, International journal of cardiology.

[22]  J. Cheatham,et al.  Clinical and Hemodynamic Outcomes up to 7 Years After Transcatheter Pulmonary Valve Replacement in the US Melody Valve Investigational Device Exemption Trial , 2015, Circulation.

[23]  M. Seckeler,et al.  Selective Pulmonary Vasodilation Improves Ventriculovascular Coupling and Gas Exchange in a Patient with Unrepaired Single-Ventricle Physiology , 2015, Pulmonary circulation.

[24]  E. Kowalik,et al.  High sensitivity troponin T in adult congenital heart disease. , 2015, International journal of cardiology.

[25]  M. Friedberg,et al.  Exercise echocardiography demonstrates biventricular systolic dysfunction and reveals decreased left ventricular contractile reserve in children after tetralogy of Fallot repair. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  C. Broberg,et al.  Defining heart failure in adult congenital heart disease , 2014 .

[27]  K. Sørensen,et al.  Bosentan Improves Exercise Capacity in Adolescents and Adults After Fontan Operation: The TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) Study , 2014, Circulation.

[28]  G. Lewis,et al.  Exercise Oscillatory Ventilation in Patients With Fontan Physiology , 2014, Circulation. Heart failure.

[29]  A. Opotowsky,et al.  Inadequate venous return as a primary cause for Fontan circulatory limitation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  John K. Triedman,et al.  PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary , 2014 .

[31]  Nandini Dendukuri,et al.  Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010 , 2014, Circulation.

[32]  J. Triedman,et al.  Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. , 2014, American journal of physiology. Heart and circulatory physiology.

[33]  K. Dimopoulos,et al.  Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival , 2014, Journal of Cardiovascular Magnetic Resonance.

[34]  Joseph D. Kay,et al.  Clinical research priorities in adult congenital heart disease. , 2014, International journal of cardiology.

[35]  N. Smart,et al.  Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure: a systematic review and meta-analysis. , 2013, JACC. Heart failure.

[36]  J. Roos‐Hesselink,et al.  Association between N-terminal pro-brain natriuretic peptide and quality of life in adult patients with congenital heart disease , 2013, Cardiology in the Young.

[37]  R. Friedman,et al.  Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States. , 2013, Congenital heart disease.

[38]  Mark J Schuuring,et al.  High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease. , 2013, Congenital heart disease.

[39]  A. Opotowsky,et al.  Physical activity is associated with improved aerobic exercise capacity over time in adults with congenital heart disease. , 2013, International journal of cardiology.

[40]  K. Dimopoulos,et al.  Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. , 2013, International journal of cardiology.

[41]  T. Takken,et al.  Systematic review of the effects of physical exercise training programmes in children and young adults with congenital heart disease. , 2013, International journal of cardiology.

[42]  A. E. van den Bosch,et al.  N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. , 2013, Journal of the American College of Cardiology.

[43]  R. Speich,et al.  Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. , 2013, International journal of cardiology.

[44]  C. Ukomadu,et al.  Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. , 2013, International journal of cardiology.

[45]  A. Redington,et al.  The failing right ventricle in congenital heart disease. , 2013, The Canadian journal of cardiology.

[46]  Mark J Schuuring,et al.  Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial , 2013, European journal of heart failure.

[47]  K. Dimopoulos,et al.  Abnormal Lung Function in Adults With Congenital Heart Disease: Prevalence, Relation to Cardiac Anatomy, and Association With Survival , 2013, Circulation.

[48]  A. Opotowsky.  Abnormal spirometry in congenital heart disease: where do we go from here? , 2013, Circulation.

[49]  M. Haissaguerre,et al.  Biventricular pacing in patients with Tetralogy of Fallot: non-invasive epicardial mapping and clinical impact. , 2013, International journal of cardiology.

[50]  A. Zwinderman,et al.  Effect of Valsartan on Systemic Right Ventricular Function: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial , 2013, Circulation.

[51]  Joseph D. Kay,et al.  Aortic Root Dilatation in Adults with Surgically Repaired Tetralogy of Fallot: A Multicenter Cross-Sectional Study , 2013, Circulation.

[52]  A. E. van den Bosch,et al.  The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. , 2012, Journal of the American College of Cardiology.

[53]  K. Hill,et al.  Percutaneous interventions in high‐risk patients following mustard repair of transposition of the great arteries , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[54]  J. Child,et al.  Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome. , 2012, The American journal of cardiology.

[55]  C. Ayers,et al.  The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation). , 2012, Journal of the American College of Cardiology.

[56]  A. E. van den Bosch,et al.  The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review , 2012, Cardiology in the Young.

[57]  K. Dimopoulos,et al.  Echocardiographic Predictors of Outcome in Eisenmenger Syndrome , 2012, Circulation.

[58]  J. Newburger,et al.  Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management A Scientific Statement From the American Heart Association , 2012, Circulation.

[59]  B. Mulder,et al.  Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial. , 2012, European heart journal.

[60]  Harshal R. Patil,et al.  Potential adverse cardiovascular effects from excessive endurance exercise. , 2012, Mayo Clinic proceedings.

[61]  C. Broberg,et al.  Does anticoagulation in Eisenmenger syndrome impact long-term survival? , 2012, Congenital heart disease.

[62]  Rebecca G. Wells,et al.  The Precarious State of the Liver After a Fontan Operation: Summary of a Multidisciplinary Symposium , 2012, Pediatric Cardiology.

[63]  B. Sarubbi,et al.  Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. , 2012, International journal of cardiology.

[64]  K. Dimopoulos,et al.  B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy , 2012, Heart.

[65]  A. Opotowsky,et al.  Discovery and management of diaphragmatic hernia related to abandoned epicardial pacemaker wires in a pregnant woman with {S,L,L} transposition of the great arteries. , 2012, Congenital heart disease.

[66]  J. Newburger,et al.  Neurodevelopmental outcomes after congenital heart surgery and strategies for improvement , 2012, Current opinion in cardiology.

[67]  D. Pennell,et al.  Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). , 2012, International journal of cardiology.

[68]  D. Grobbee,et al.  Circumstances of death in adult congenital heart disease. , 2012, International journal of cardiology.

[69]  J. Rhodes,et al.  Paediatric cardiac rehabilitation in congenital heart disease: a systematic review , 2012, Cardiology in the Young.

[70]  S. Tyagi,et al.  Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study. , 2011, Congenital heart disease.

[71]  R. Nolan,et al.  Parental Overprotection and Heart-Focused Anxiety in Adults with Congenital Heart Disease , 2011, International journal of behavioral medicine.

[72]  B. McCrindle,et al.  A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. , 2011, Journal of the American College of Cardiology.

[73]  E. Tay,et al.  Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy. , 2011, International journal of cardiology.

[74]  J. Dearani,et al.  Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. , 2011, Journal of the American College of Cardiology.

[75]  Joseph D. Kay,et al.  Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. , 2011, The American journal of cardiology.

[76]  J. Rychik,et al.  Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After the Fontan Operation: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial , 2011, Circulation.

[77]  C. Silversides,et al.  Generalised muscle weakness in young adults with congenital heart disease , 2011, Heart.

[78]  Helmut Baumgartner,et al.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). , 2010, European heart journal.

[79]  B. Kogon,et al.  Pulmonary arterial hypertension in patients with prior atrial switch procedure for d-transposition of great arteries (dTGA). , 2010, International journal of cardiology.

[80]  W. Chung,et al.  Enalapril in Infants With Single Ventricle: Results of a Multicenter Randomized Trial , 2010, Circulation.

[81]  Dionne A. Graham,et al.  The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. , 2010, Journal of the American College of Cardiology.

[82]  G. Abou-Alfa,et al.  Hepatocellular carcinoma in two patients with cardiac cirrhosis. , 2010, European journal of gastroenterology & hepatology.

[83]  C. Silversides,et al.  CorrespondenceResearch CorrespondenceIntraoperative High-Density Global Mapping in Adult-Repaired Tetralogy of Fallot: Altered Left Ventricular and Right Ventricular Activation and Implications for Resynchronization Strategies , 2010 .

[84]  D. Grobbee,et al.  Mortality in adult congenital heart disease. , 2010, European heart journal.

[85]  K. Iversen,et al.  Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. , 2010, European heart journal.

[86]  K. Fox,et al.  Exercise training in adults with congenital heart disease: feasibility and benefits. , 2010, International journal of cardiology.

[87]  K. Dimopoulos,et al.  Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension , 2010, Circulation.

[88]  G. Veldtman,et al.  Abstract 1774: Structural and Functional Uncoupling of Liver Performance in the Fontan Circulation , 2009 .

[89]  A. Marelli,et al.  Atrial Arrhythmias in Adults With Congenital Heart Disease , 2009, Circulation.

[90]  Emily A. Kuhl,et al.  Depression and anxiety in adult congenital heart disease: predictors and prevalence. , 2009, International journal of cardiology.

[91]  A. Opotowsky,et al.  Trends in hospitalizations for adults with congenital heart disease in the U.S. , 2009, Journal of the American College of Cardiology.

[92]  E. Martínez-Quintana,et al.  Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients. , 2009, Congenital heart disease.

[93]  T. Delhaas,et al.  Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates , 2009, Heart.

[94]  T. Mattoo,et al.  Nephropathy in patients after Fontan palliation. , 2009, International journal of cardiology.

[95]  K. Gauvreau,et al.  Cardiac Resynchronization Therapy (and Multisite Pacing) in Pediatrics and Congenital Heart Disease: Five Years Experience in a Single Institution , 2009, Journal of cardiovascular electrophysiology.

[96]  Geoffrey I. Webb,et al.  Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. , 2008, International journal of cardiology.

[97]  L. Harris,et al.  Sudden Death and Defibrillators in Transposition of the Great Arteries With Intra-atrial Baffles: A Multicenter Study , 2008, Circulation. Arrhythmia and electrophysiology.

[98]  N. Best,et al.  Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart Disease , 2008, Circulation.

[99]  N. Wenger.  Current status of cardiac rehabilitation. , 2008, Journal of the American College of Cardiology.

[100]  L. Harris,et al.  Implantable Cardioverter-Defibrillators in Tetralogy of Fallot , 2008, Circulation.

[101]  Daniel B Vigneron,et al.  Abnormal brain development in newborns with congenital heart disease. , 2007, The New England journal of medicine.

[102]  S. D. de Ferranti,et al.  Obesity Is a Common Comorbidity in Children With Congenital and Acquired Heart Disease , 2007, Pediatrics.

[103]  B. Stedman,et al.  Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study , 2007, Journal of Clinical Pathology.

[104]  R. Holubkov,et al.  Carvedilol for children and adolescents with heart failure: a randomized controlled trial. , 2007, JAMA.

[105]  M. Rubens,et al.  Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. , 2007, Journal of the American College of Cardiology.

[106]  A. Taylor,et al.  Physiological consequences of percutaneous pulmonary valve implantation: the different behaviour of volume- and pressure-overloaded ventricles. , 2007, European heart journal.

[107]  K. Dimopoulos,et al.  Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease , 2007, Heart.

[108]  K. Norozi,et al.  A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot , 2007, Cardiology in the Young.

[109]  Vera Bittner,et al.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr , 2007, Circulation.

[110]  M. Massin,et al.  Noncardiac comorbidities of congenital heart disease in children , 2007, Acta paediatrica.

[111]  K. Fox,et al.  Physical activity levels in adults with congenital heart disease , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[112]  Donald J Hagler,et al.  Results of transcatheter Fontan fenestration to treat protein losing enteropathy , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[113]  W. Book,et al.  Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. , 2007, The American journal of cardiology.

[114]  E. Walsh,et al.  Arrhythmias in Adult Patients With Congenital Heart Disease , 2007, Circulation.

[115]  R. Fattori,et al.  A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. , 2007, International journal of cardiology.

[116]  A. Marelli,et al.  Congenital Heart Disease in the General Population: Changing Prevalence and Age Distribution , 2006, Circulation.

[117]  E P Walsh,et al.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair , 2006, Heart.

[118]  M. Gupta,et al.  Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome: A Preliminary Observational Study , 2006, Circulation.

[119]  M. Gladwin,et al.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. , 2006, Circulation.

[120]  B. Stedman,et al.  Hepatic changes in the failing Fontan circulation , 2006, Heart.

[121]  K. Gauvreau,et al.  Sustained Effects of Cardiac Rehabilitation in Children With Serious Congenital Heart Disease , 2006, Pediatrics.

[122]  Philip Moons,et al.  Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey. , 2006, European heart journal.

[123]  Paul Khairy,et al.  Transvenous Pacing Leads and Systemic Thromboemboli in Patients With Intracardiac Shunts: A Multicenter Study , 2006, Circulation.

[124]  A. Taylor,et al.  Physiological and Clinical Consequences of Relief of Right Ventricular Outflow Tract Obstruction Late After Repair of Congenital Heart Defects , 2006, Circulation.

[125]  A. Redington,et al.  Recovery of Left Ventricular Systolic Function After Biventricular Resynchronization Pacing in a Child With Repaired Tetralogy of Fallot and Severe Biventricular Dysfunction , 2006 .

[126]  E. Rosenthal,et al.  Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. , 2005, Journal of the American College of Cardiology.

[127]  K. Gauvreau,et al.  Impact of Cardiac Rehabilitation on the Exercise Function of Children With Serious Congenital Heart Disease , 2005, Pediatrics.

[128]  A. Ducharme,et al.  Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles: A Multicenter, Randomized, Placebo-Controlled Clinical Trial , 2005, Circulation.

[129]  E. Antman,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[130]  G. Hutchins,et al.  Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. , 2005, The Journal of thoracic and cardiovascular surgery.

[131]  W. Hopman,et al.  Effect of activity restriction owing to heart disease on obesity. , 2005, Archives of pediatrics & adolescent medicine.

[132]  J. Rychik,et al.  Impact of congenital heart disease on cerebrovascular blood flow dynamics in the fetus , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[133]  D. Hsu,et al.  Cardiac transplantation after the Fontan or Glenn procedure. , 2004, Journal of the American College of Cardiology.

[134]  Tal Geva,et al.  Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[135]  R. Kim,et al.  840-1 Myocardial fibrosis patterns correlate with adverse right ventricular morphology and function in patients with repaired conotruncal heart defects , 2004 .

[136]  J. Hoffman,et al.  Prevalence of congenital heart disease. , 2004, American heart journal.

[137]  B. Suys,et al.  Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium , 2004, Heart.

[138]  C. Silversides,et al.  Pulmonary thrombosis in adults with Eisenmenger syndrome. , 2003, Journal of the American College of Cardiology.

[139]  A. Parkhomenko,et al.  Management of grown up congenital heart disease. , 2003, European heart journal.

[140]  M. Simoons,et al.  Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). , 2003, European heart journal.

[141]  K. Gauvreau,et al.  Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. , 2003, The American journal of cardiology.

[142]  J. W. Moore,et al.  Afterload Reduction Therapy in Patients Following Intraatrial Baffle Operation for Transposition of the Great Arteries , 2002, Pediatric Cardiology.

[143]  S. Anker,et al.  Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease , 2002, Circulation.

[144]  Salim Yusuf,et al.  Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). , 2002, American heart journal.

[145]  S. Siu,et al.  Heart Failure and Ventricular Dysfunction in Patients With Single or Systemic Right Ventricles , 2002, Circulation.

[146]  E. Foster,et al.  Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. , 2001, The American journal of cardiology.

[147]  Geoffrey I. Webb,et al.  Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. , 2001, The American journal of cardiology.

[148]  S. Siu,et al.  Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. , 2001, Journal of the American College of Cardiology.

[149]  S. Siu,et al.  Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.

[150]  S. Siu,et al.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study , 2000, The Lancet.

[151]  I. Gessner,et al.  Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. , 2000, Journal of the American College of Cardiology.

[152]  F. Sakamaki,et al.  Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome , 2000, Heart.

[153]  E. Jaeggi,et al.  Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. , 2000, Journal of the American College of Cardiology.

[154]  E. Jaeggi,et al.  Right ventricular dysfunction in congenitally corrected transposition of the great arteries. , 1999, The American journal of cardiology.

[155]  P. Presbitero,et al.  Eisenmenger syndrome. Factors relating to deterioration and death. , 1998, European heart journal.

[156]  W. Gersony,et al.  Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. , 1998, Circulation.

[157]  I. Dähnert,et al.  Renal impairment in patients with long‐standing cyanotic congenital heart disease , 1998, Acta paediatrica.

[158]  P. Monagle,et al.  Coagulation abnormalities after Fontan procedures. , 1998, The Journal of thoracic and cardiovascular surgery.

[159]  J. Triedman,et al.  Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. , 1997, Journal of the American College of Cardiology.

[160]  L. Mahony,et al.  Enalapril does not enhance exercise capacity in patients after Fontan procedure. , 1997, Circulation.

[161]  D. McElhinney,et al.  Routine primary repair of tetralogy of Fallot in neonates and infants less than three months of age. , 1995, The Annals of thoracic surgery.

[162]  W. Edwards,et al.  Late results of systemic atrioventricular valve replacement in corrected transposition. , 1995, The Journal of thoracic and cardiovascular surgery.

[163]  A. Redington,et al.  Diastolic ventricular function after the Fontan operation. , 1992, The American journal of cardiology.

[164]  J. Jarmakani,et al.  Partial Fontan: advantages of an adjustable interatrial communication. , 1991, The Annals of thoracic surgery.

[165]  A. Redington,et al.  Abnormal patterns of intraventricular flow and diastolic filling after the Fontan operation: evidence for incoordinate ventricular wall motion. , 1991, British heart journal.

[166]  J. Lock,et al.  Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. , 1990, Circulation.

[167]  G. Danovitch,et al.  Renal function and urate metabolism in late survivors with cyanotic congenital heart disease. , 1986, Circulation.

[168]  D. G. Ritter,et al.  Complete Atrioventricular Block in Patients with Atrioventricular Discordance , 1983, Circulation.

[169]  W. Neches,et al.  Hemodynamic function after the Mustard operation for transposition of the great arteries. , 1983, The American journal of cardiology.

[170]  F. Fontan,et al.  Surgical repair of tricuspid atresia , 1971, Thorax.

[171]  J. Kirklin.  The Tetralogy of Fallot. , 1968, The American journal of roentgenology, radium therapy, and nuclear medicine.

[172]  P. Wood.  The Eisenmenger Syndrome , 1958 .

[173]  H. B. Sprague,et al.  THE TETRALOGY OF FALLOT: REPORT OF A CASE IN A NOTED MUSICIAN, WHO LIVED TO HIS SIXTIETH YEAR , 1929 .

[174]  The Open-Air Treatment of Consumption , 1899, The Hospital.

[175]  J. Roos‐Hesselink,et al.  Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease. , 2016, International journal of cardiology.

[176]  A. Atz,et al.  Effect of Sildenafil on Pressure–Volume Loop Measures of Ventricular Function in Fontan Patients , 2015, Pediatric Cardiology.

[177]  A. Opotowsky,et al.  The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. , 2014, Heart failure clinics.

[178]  John K. Triedman,et al.  Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery , 2008, Circulation.

[179]  C. Mavroudis,et al.  J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. , 2007, The Annals of thoracic surgery.

[180]  M. Gatzoulis,et al.  Double-Blind , Randomized , Placebo-Controlled Study Bosentan Therapy in Patients With Eisenmenger Syndrome : A Multicenter , 2006 .

[181]  R. Franklin,et al.  Impact of Fontan operation on left ventricular size and contractility in tricuspid atresia. , 1990, Circulation.

[182]  E. Blackstone,et al.  The early results of treatment of simple transposition in the current era. , 1988, The Journal of thoracic and cardiovascular surgery.

[183]  E. Glasgow,et al.  Nephropathy in cyanotic congenital heart disease. , 1977, Clinical nephrology.